Gland Pharma to invest $21 million in US subsidiary deal
In short
Gland Pharma said it will invest $21 million in its US subsidiary. That subsidiary will buy a 60% stake in a new company called Novelstar Pharma.
This matters because it shows Gland Pharma is expanding in America. The report does not say when the deal closes or how much business it will add.
What the reporting says
Gland Pharma said it will invest $21 million in its US subsidiary, which will acquire a 60% stake in newly incorporated Novelstar Pharma. The move is tied to the company’s expansion in America, according to the reporting. The immediate commercial impact, including revenue, timing, and integration details, is not stated in the available reporting.
Why it matters
Gland Pharma plans to invest $21 million in its US subsidiary, and that unit will acquire a 60% stake in newly incorporated Novelstar Pharma. The reporting ties the move to the company’s expansion in America. The source does not state the closing date, financial contribution, or other deal terms beyond the stake and investment amount.